NCT06064656View on ClinicalTrials.gov

A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)

CompletedOBSERVATIONAL
Enrollment

131

Participants

Timeline

Start Date

June 29, 2023

Primary Completion Date

September 22, 2023

Study Completion Date

September 29, 2023

Conditions
Fibrodysplasia Ossificans Progressiva (FOP)
Interventions
OTHER

Non-Interventional

No study treatment will be administered in this study.

Trial Locations (1)

10591

Regeneron, Tarrytown

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY